Alfonso
Soto Gonzalez
![Foto de Alfonso](/img/nophoto.png)
![Foto de University Health Network](/img/noimage_org.png)
University Health Network
Toronto, CanadáPublicacións en colaboración con investigadores/as de University Health Network (1)
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184